Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioTime, Inc.
(NY:
BTX
)
4.180
USD
-0.050 (-1.18%)
Streaming Delayed Price
/ Updated:
10:09 AM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about BioTime, Inc.
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
BioTime (BTIM) Announces Receipt of $8M From Warrant Exercise
May 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5617552 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime Announces Receipt of $8 Million from Early Exercise of Warrants
May 10, 2010
from
Business Wire News Releases
Next Resistance Level for Biotime (BTIM) is $7.69
May 10, 2010
from
Comtex SmarTrend® News Briefs
SmarTrend Detects Continued Buying Pressure in Shares of Biotime (BTIM)
May 07, 2010
from
Comtex SmarTrend® News Briefs
Biotime Falls Thru $7.50: Enters New Trading Range (BTIM)
May 06, 2010
from
Comtex SmarTrend® News Briefs
BioTime Announces First Quarter 2010 Financial Results and Recent Corporate Developments
May 05, 2010
from
Business Wire News Releases
BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition
May 03, 2010
from
Business Wire News Releases
BioTime, Inc. Provides Additional Information on Acquisition of Promissory Notes in Connection with Planned Acquisition of ES Cell International Pte Ltd.
April 29, 2010
from
Business Wire News Releases
BioTime (BTIM) Shares Trade Lower on ESI Acquisition News
April 29, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5577841 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime, Inc. Announces Agreement to Acquire ES Cell International
April 29, 2010
from
Business Wire News Releases
Rally Rolls On!
March 16, 2010
The stock market indices ended up higher again on Tuesday with more new 2010 highs reached today on the S&P 500 at just over 1160. The day started out with backing and filling that held support, which...
Read More
from
Harry's Hotline by Harry Boxer
Unusual 11 Mid-Day Movers 3/16: ICGN, XFN, BTIM, BLTI, ORCD Higher; FRBK, WHI, UWBK, EONC Lower
March 16, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5443063 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime, Inc. Reports Peer-Reviewed Scientific Publication on the Reversal of the Developmental Aging of Normal Human Cells
March 16, 2010
from
Business Wire News Releases
BioTime, Inc. (BTIM) Posts Q4 EPS of $0.04, Misses Y/Y; Revs Heavy
March 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5425169 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime Announces Fourth Quarter and Fiscal Year-End 2009 Financial Results and Recent Corporate Developments
March 10, 2010
from
Business Wire News Releases
BioTime (BTIM) Announces Results from Hextrend in Hemodynamically Unstable Trauma Patients
February 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5312237 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime Reports Results from Independent Hextend® Study
February 05, 2010
-- First Report on Hextend for Initial Fluid Resuscitation at a Level I Trauma Center --
Read More
from
Business Wire News Releases
BioTime (BTIM) Subsidiary OncoCyte Completes Funding of Second Tranche Through 3M Common Private Placement
January 07, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5230246 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime Subsidiary OncoCyte Corporation Receives Second $2,000,000 Equity Tranche; BioTime Plans Additional $2,250,000 Investment
January 07, 2010
from
Business Wire News Releases
BioTime (BTIM) Initiates Shipments of Stem Cells to Millipore Corp.
January 05, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5222109 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime Commences Shipment of Stem Cell Research Products to Millipore
January 05, 2010
from
Business Wire News Releases
Endo, Celgene lead drug stocks lower
December 08, 2009
Drug stocks retreat with the broader market, led by biotech groups Endo Pharmaceuticals and Celgene.
Read More
category
Market News
,
BTIM
,
Biotechnology
, and 9 more.
from
MarketWatch
BioTime CEO Dr. Michael West to Ring The Opening Bell at the New York Stock Exchange
December 04, 2009
from
Business Wire News Releases
BioTime (BTIM) Posts Q3 Loss of $0.11, Wider Y/Y; Revs Higher
November 24, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5138268 for the full story.
Read More
from
StreetInsider.com News Articles
BioTime, Inc. Announces Third Quarter 2009 Financial Results and Update on Recent Developments
November 24, 2009
from
Business Wire News Releases
BioTime CEO Dr. Michael West to Present at Stem Cells USA & Regenerative Medicine Congress 2009
November 12, 2009
from
Business Wire News Releases
The Week in Review: International Initiatives
October 24, 2009
Boehringer Ingelheim will invest $149 million in China for new facilities including an R&D center; Simcere Pharma (????) acquired China rights to a dual-mechanism cancer drug from OSI Pharma;...
Read More
from
ChinaBio® Today
BioTime, Inc. Announces Approval For NYSE Amex Listing
October 22, 2009
from
Business Wire News Releases
Chief Medical Officer of BioTime’s Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China
October 22, 2009
from
Business Wire News Releases
BioTime Investigating Stem Cells to Treat Cancer
October 22, 2009
BioTime, Inc. announced that Dr. David Jin, Chief Medical Officer of BioTime’s newly formed subsidiary, OncoCyte Corporation, will present the keynote address at the Fifth Chinese Congress on Stem Cell...
Read More
from
ChinaBio® Today
< Previous
1
2
...
5
6
7
8
9
10
11
12
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here